Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 38, 2008 - Issue 5
68
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Comparative evaluation of absorption, distribution, and excretion of YM758, a novel If channel inhibitor, between albino and non-albino rats

, , , , , & show all
Pages 527-539 | Received 03 Feb 2008, Accepted 18 Feb 2008, Published online: 22 Sep 2008

References

  • Bucchi A, Barbuti A, Baruscotti M, DiFrancesco D. Heart rate reduction via selective ‘funny’ channel blockers. Current Opinion in Pharmacology 2007; 7: 208–213
  • Buckberg GD, Fixler DE, Archie JP, Hoffman JI. Experimental subendocardial ischemia in dogs with normal coronary arteries. Circulation Research 1972; 30: 67–81
  • Indolfi C, Guth BD, Miura T, Miyazaki S, Schulz R, Ross J, Jr. Mechanisms of improved ischemic regional dysfunction by bradycardia. Studies on UL-FS 49 in swine. Circulation 1989; 80: 983–993
  • Ings RM. The melanin binding of drugs and its implications. Drug Metabolism Reviews 1984; 15: 1183–1212
  • Ohta K, Fukasawa Y, Yamaguchi J, Kohno Y, Fukushima K, Suwa T, Awazu S. Retention mechanism of imidazoles in connective tissue. IV. Identification of a nucleophilic imidazolone metabolite in rats. Biological and Pharmaceutical Bulletin 1998; 21: 1334–1337
  • Oitate M, Hirota T, Koyama K, Inoue S, Kawai K, Ikeda T. Covalent binding of radioactivity from [14C]rofecoxib, but not [14C]celecoxib or [14C]CS-706, to the arterial elastin of rats. Drug Metabolism and Disposition 2006; 34: 1417–1422
  • Oitate M, Hirota T, Murai T, Miura S, Ikeda T. Covalent binding of rofecoxib, but not other cyclooxygenase-2 inhibitors, to allysine aldehyde in elastin of human aorta. Drug Metabolism and Disposition 2007b; 35: 1846–1852
  • Oitate M, Hirota T, Takahashi M, Murai T, Miura S, Senoo A, Hosokawa T, Oonishi T, Ikeda T. Mechanism for covalent binding of rofecoxib to elastin of rat aorta. Journal of Pharmacology and Experimental Therapeutics 2007a; 320: 1195–1203
  • Ono C, Yamada M, Makoto T. Absorption, distribution and excretion of 14C-chloroquine after single oral administration in albino and pigmented rats: Binding characteristics of chloroquine-related radioactivity to melanin in-vivo. Journal of Pharmacy and Pharmacology 2003; 55: 1647–1654
  • Opie L. Trial alert. Cardiovascular Drugs and Therapy 1989; 3: 795–796
  • Ragueneau I, Laveille C, Jochemsen R, Resplandy G, Funck-Brentano C, Jaillon P. Pharmacokinetic–pharmacodynamic modeling of the effects of ivabradine, a direct sinus node inhibitor, on heart rate in healthy volunteers. Clinical Pharmacology and Therapeutics 1998; 64: 192–203
  • Roth W, Bauer E, Heinzel G, Cornelissen PJ, Van Tol RG, Jonkman JH, Zuiderwijk PB. Zatebradine: Pharmacokinetics of a novel heart-rate-lowering agent after intravenous infusion and oral administration to healthy subjects. Journal of Pharmaceutical Sciences 1993; 82: 99–106
  • Schmidt A, Busse WD, Garthoff B, Gau W, Ritter W, Wünsche C, Buddecke E. Influence of muzolimine on arterial wall elastin. Biochemical Pharmacology 1984; 33: 1915–1921
  • Tanaka M, Ono C, Yamada M. Absorption, distribution and excretion of 14C-levofloxacin after single oral administration in albino and pigmented rats: Binding characteristics of levofloxacin-related radioactivity to melanin in-vivo. Journal of Pharmacy and Pharmacology 2004; 56: 463–469
  • Vesely I. The role of elastin in aortic valve mechanics. Journal of Biomechanics 1998; 31: 115–123

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.